FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073995 [Registered on: 18/09/2024] Trial Registered Prospectively
Last Modified On: 11/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   Nebulised dexmedetomidine efficacy in reducing haemodynamic response to laryngoscopy and intubation. 
Scientific Title of Study   Evaluation of efficacy of nebulised dexmedetomidine in attenuation of haemodynamic response to laryngoscopy and intubation. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tarandeep Singh Bajwa 
Designation  post graduate student 
Affiliation  Maharishi markandeshwar medical college and hospital 
Address  Department of Anaesthesia, Maharishi Markandeshwar Medical college and Hospital,Kumarhatti,solan
solan ,Himachal Pradesh
Solan
HIMACHAL PRADESH
173229
India 
Phone  919876388963  
Fax    
Email  Taranbajwa1414@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sachin k Gupta 
Designation  Professor  
Affiliation  Maharishi Markandeshwar Medical college and Hospital 
Address  Department of Anaesthesia,Maharishi Markandeshwar Medical College and Hospital,Kumarhatti,solan
solan,himachal Pradesh.
Solan
HIMACHAL PRADESH
173229
India 
Phone  9877484849  
Fax    
Email  sachinkg78@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tarandeep Singh Bajwa 
Designation  post graduate student 
Affiliation  Maharishi markandeshwar medical college and hospital 
Address  Department of Anaesthesia, Maharishi Markandeshwar Medical college and Hospital,Kumarhatti,solan
solan ,Himachal Pradesh
Solan
HIMACHAL PRADESH
173229
India 
Phone  919876388963  
Fax    
Email  Taranbajwa1414@gmail.com  
 
Source of Monetary or Material Support  
Maharishi Markandeshwar medical college and Hospital,Kumarhatti,solan,Himachal Pradesh,INDIA. PIN code-173229 
 
Primary Sponsor  
Name  Dr Tarandeep Singh Bajwa 
Address  Department of Anaesthesia,Maharishi Markandeshwar medical college and Hospital,Kumarhatti,solanHimachal Pradesh,INDIA. PIN code-173229 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tarandeep singh bajwa  Maharishi Markandeshwar medical college and Hospital,Kumarhatti,solan  o.t complex, third floor ,Department of Anaesthesia,Maharishi Markandeshwar medical college and Hospital,Kumarhatti,solan
Solan
HIMACHAL PRADESH 
9876388963

taranbajwa1414@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Maharishi Markandeshwar medical college and hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nebulised dexmedetomidine will be given and attenuation of haemodynamic response to laryngoscopy and intubation will be recorded.  Nebulised Dexmedetomidine will be given at a dosage of 1 mcg/kg that is to be mixed with the saline to a total volume of 5 ml and the nebulisation will be administered with nebuliser facemask for the time period of 10 min before the induction of anaesthesia in the sitting position and response will be noted at time. Injections of midazolam (30 mcg/kg), glycopyrrolate (10 mcg/kg), and nalbuphine (0.1 mg/kg) will be used to premedicate patients. They will also be preoxygenated for three minutes, induced with propofol (2 mg/kg), monitored for dosage amounts until verbal response is lost, and given vecuronium (0.1 mg/kg) as a muscle relaxant to aid in intubation. The consultant anesthesiologist will do a direct laryngoscopy (with the proper-sized Macintosh blade), intubate the patient using an appropriately-sized endotracheal tube, and then link them to a ventilator 10 minutes after intubation, the critical indicators such as the heart rate , the blood pressure (systolic , diastolic and the mean arterial pressure will be noted by the baseline vitals, the post-nebulization (post-neb), and the post-intubation at 1, 5, and 10 minutes will be recorded by an anaesthesia resident who is not currently participating in the project. Diclofenac 75 mg injections will be given intraoperatively to all patients. After the surgery, the neuromuscular blockade will be removed by injecting glycopyrrolate and neostigmine. The patient will then be extubated if they have met the extubation requirements, and they will then be sent to the post-anesthesia care unit. 
Comparator Agent  Evaluation of efficacy of nebulised normal saline in attenuation of haemodynamic response to laryngoscopy and intubation.  Normal saline 5 ml nebulisation will be administered with a nebuliser face mask for time period of 10 minute before induction of anesthesia in sitting position.Injections of midazolam (30 mcg/kg), glycopyrrolate (10 mcg/kg), and nalbuphine (0.1 mg/kg) will be used to premedicate patients. They will also be preoxygenated for three minutes, induced with propofol (2 mg/kg), monitored for dosage amounts until verbal response is lost, and given vecuronium (0.1 mg/kg) as a muscle relaxant to aid in intubation. The consultant anesthesiologist will do a direct laryngoscopy (with the proper-sized Macintosh blade), intubate the patient using an appropriately-sized endotracheal tube, and then link them to a ventilator 10 minutes after intubation, the critical indicators such as the heart rate , the blood pressure (systolic , diastolic and the mean arterial pressure will be noted by the baseline vitals, the post-nebulization (post-neb), and the post-intubation at 1, 5, and 10 minutes will be recorded by an anaesthesia resident who is not currently participating in the project. Diclofenac 75 mg .Injections will be given intraoperatively to all patients. After the surgery, the neuromuscular blockade will be removed by injecting glycopyrrolate and neostigmine. The patient will then be extubated if they have met the extubation requirements, and they will then be sent to the post-anesthesia care unit. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  o American Society of Anaesthesiologists class 1 and 2 patients.
o Mallampati Grading I and II.
o Undergoing elective surgery under general anaesthesia and endotracheal intubation needed.
o Patient between age 18 to 60 years. 
 
ExclusionCriteria 
Details  o American Society of Anaesthesiologists class III and IV.
o Patient not consenting for the study.
o Predicted difficulty airway.
o Known allergy to dexmedetomidine
o Patient on B-blockers
o Pregnant females.
o Kidney failure
o Uncontrolled hypertensive patient
o Seizure disorders.
o Patient taking medications such as anti-depressants or anti-psychotics.
o Patients with decrease cardiac output.
o Obese patient with Body mass index of more than 30 kg/metre square.
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Study is to evaluate the two groups in order to assess the following
VITALS: heart rate, systolic and diastolic blood pressure, mean arterial pressure. 
Heart rate , the blood
pressure (systolic , diastolic and the mean arterial pressure will be noted by the baseline vitals, the post-nebulization (post-neb), and the post-intubation at 1, 5, and 10 minutes will be noted. 
 
Secondary Outcome  
Outcome  TimePoints 
To study any adverse effect of drug such as bradycardia,, hypotension, coughing and sore throat.  In postoperative ward after extubation. 
 
Target Sample Size   Total Sample Size="160"
Sample Size from India="160" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To evaluate the effect of nebulised dexmedetomidine in attenuation of haemodynamic response  to laryngoscopy and intubation.Nebulised dexmedetomidine will be given at dosage of 1mcg/kg that is to be mixed with the saline to a total volume of 5 ml and the nebulisation will be given with the nebulisation mask for period of 10 min in sitting position before induction of anesthesia .Injection of midazolam 30 mcg/kg ,injection Glycopyrollate 20 mcg/kg,and Nalbuphine 0.1mg/kg will be given to premedicate the patient .Patient will also be pre oxygenated for 3 minutes and propofol at a dose of 2 mg/kg will be given to induce the patient and patient will be monitored for doseage amounts until verbal response is lost and given vecuronium at dose 0.1mg/kg as a muscle relaxant to help in the intubation.Consultant anaesthesiologist will do  Direct laryngyoscopy with appropriate size Macintosh blade and intubate the patient using appropriate size endotracheal tube and link It to the ventilator 10 minutes after intubation ,
the critical indicators such as THE HEART RATE ,THE BLOOD PRESSURE{ SYSTOLIC BLOOD PRESSURE,DIASTOLIC PRESSURE,MEAN ARTERIAL PRESSURE)will be noted via the baseline vitals.Post nebulisation and post intubation at 1 minute,5 minute ,10 minute by an anesthesia resident who is not currently participating in the project.Diclofenac 75 mg injection will be given intraopertively to all patients.After surgery the neuromuscular blockade will be removed by injection glycopyrollate and neostigmine and then patient will be extubated if they have met the extubation requirement and they will then be send to the post anesthsia care unit.
 
Close